Therapeutic agent, method of treatment and method for predicting the severity of systemic inflammatory response syndrome (SIRS), diseases caused or accompanied by neutrophil activation

Assignee

• National University Corporation Okayama University

Inventors

• Kosuke Kuroda (5 patents)
• Hiroshi MORIMATSU (1 patents)
• Hidenori WAKE (2 patents)
• Shuji Mori (7 patents)
• Masahiro Nishibori (6 patents)
• Hideo Takahashi (5 patents)
• Keyue Liu (2 patents)
• Kiyoshi Teshigawara (2 patents)
• Masakiyo Sakaguchi (9 patents)

View full patent text on Google Patents →